Between-visit care represents a substantial and underrecognized component of health care utilization in pediatric inflammatory bowel disease
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izag097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Jeannie S Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Gastroenterology, Hepatology, and Nutrition, Rady Children's Hospital, San Diego, CA 92123, United States. Hauptthemen laut MEDLINE: Patient Acceptance of Health Care, Inflammatory Bowel Diseases, Ambulatory Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Children with inflammatory bowel disease (IBD) require substantial health care engagement, yet traditional utilization metrics underestimate the scope of care by omitting between-visit clinical activity such as electronic messaging, telephone encounters, and results review. Pediatric-specific data describing this hidden workload remain limited.
Methods
We conducted a retrospective longitudinal cohort study of youth aged 0 to 22 years diagnosed with IBD between 2015 and 2024 at a tertiary care center. Eligible patients had ≥ 6 months of primary care prior to diagnosis and ≥ 6 months of gastroenterological follow-up postdiagnosis. From the shared electronic health record, we quantified outpatient visits, emergency care, and procedures, as well as between-visit care (portal messages from patients, telephone encounters, and clinician-patient review of results) from prediagnosis through long-term follow-up. Events were aggregated into 6-month epochs relative to diagnosis and stratified by disease severity using validated symptom indices. Predictors of between-visit care were evaluated using generalized linear mixed-effects modeling.
Results
Among 226 patients (median age 12 years; 57% male), health care utilization increased markedly during peri-diagnostic epochs. Between-visit care rose from a median of 1 event per 6 months > 1 year prediagnosis to 64 events in the year following diagnosis, and the number of these events remained persistently elevated thereafter. Higher disease severity was strongly associated with increased between-visit care. In multivariable analysis, postdiagnosis epochs, moderate-severe disease activity, and later diagnostic year independently predicted increased between-visit care (all P < .0001).
Conclusions
Between-visit care represents a substantial and clinically meaningful component of pediatric IBD management, underscoring the need for workforce planning, reimbursement models, and digital innovations to address this largely invisible clinical workload.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Divisions of Gastroenterology, Hepatology, and Nutrition, Rady Children's Hospital, San Diego, CA 92123, United States.
- Clinical Informatics, Rady Children's Hospital, San Diego, CA 92123, United States.
- Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, United States.
ORCID-Profile: Jeannie S Huang
Zitieren
APA
Huang, J. S., Bauman, L. E., Katibian, D., & Polk, D. B. (2026). Between-visit care represents a substantial and underrecognized component of health care utilization in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag097
Vancouver
Huang JS, Bauman LE, Katibian D, Polk DB. Between-visit care represents a substantial and underrecognized component of health care utilization in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag097
BibTeX
@article{Huang2026,
author = {Huang, Jeannie S and Bauman, Laura E and Katibian, David and Polk, David Brent},
title = {Between-visit care represents a substantial and underrecognized component of health care utilization in pediatric inflammatory bowel disease},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izag097}
}
EUVIMED